scholarly journals Evaluation of umbilical cord serum therapy for persistent corneal epithelial defects

2003 ◽  
Vol 87 (11) ◽  
pp. 1312-1316 ◽  
Author(s):  
R B Vajpayee
2017 ◽  
Vol 43 (5) ◽  
pp. 324-329 ◽  
Author(s):  
Neha Kamble ◽  
Namrata Sharma ◽  
Prafulla K. Maharana ◽  
Pooja Bandivadekar ◽  
Ritu Nagpal ◽  
...  

2011 ◽  
Vol 52 (2) ◽  
pp. 1087 ◽  
Author(s):  
Namrata Sharma ◽  
Manik Goel ◽  
Thirumurthy Velpandian ◽  
Jeewan S. Titiyal ◽  
Radhika Tandon ◽  
...  

Author(s):  
Arjun Srirampur

This is a Letter to the Editor. Please download the PDF or view the article in HTML.


Author(s):  
Siamak Moradian ◽  
Marzieh Ebrahimi ◽  
Azade Kanaani ◽  
Amir Faramarzi ◽  
Sare Safi

Purpose: To evaluate the role of topical umbilical cord serum (TUCS) therapy in treating corneal epithelial defects (CEDs) after diabetic vitrectomy. Methods: In this double-masked, randomized clinical trial, we included 80 eyes of 80 patients who were candidates for vitrectomy due to proliferative diabetic retinopathy complications. In cases of corneal edema obscuring the fundus view during surgery, the corneal epithelium was removed using a 6-mm trephine and a blade no.15. The day after the surgery, patients were randomly divided into two groups: (1) the TUCS group that received 20% TUCS six times/day in addition to the conventional treatment of CED and (2) the control group, which was prescribed artificial tears as placebo in addition to the conventional treatment of CED. The rate of healing of CEDs was measured via two maximum linear dimensions perpendicular to each other at the start of therapy and on postoperative days 1–5, 7, and 12. Results: Of 80 eyes, 40 were assigned to each treatment group. The mean times to complete CED healing were 2.4 ± 0.7 and 3.8 ± 2.1 days in the TUCS and control groups, respectively (P < 0.001). Persistent CED occurred in two eyes in the control group but in no eyes in the TUCS group. Conclusion: TUCS therapy may be safe and effective in healing CEDs after vitrectomy in patients with diabetes.


Author(s):  
Siamak Moradian ◽  
Marzieh Ebrahim ◽  
Azade Kanaani ◽  
Amir Faramarz ◽  
Sare Safi

This is a Reply Letter and does not have an abstract. Please download the PDF or view the article in HTML.


Author(s):  
Sota Iwatani ◽  
Takao Kobayashi ◽  
Sachiko Matsui ◽  
Akihiro Hirata ◽  
Miwa Yamamoto ◽  
...  

Objective The fetal inflammatory response syndrome (FIRS) is characterized by elevated concentrations of inflammatory cytokines in fetal blood, with preterm delivery and morbidity. Umbilical cord serum interleukin-6 (UC-s-IL-6) is an ideal marker for detecting FIRS. However, the effect of gestational age (GA) on UC-s-IL-6 levels has not been reported. This study aimed to determine the relationship between GA and UC-s-IL-6 levels, and GA-dependent cutoff values of UC-s-IL-6 levels for detecting fetal inflammation. Study Design UC-s-IL-6 concentrations were measured in 194 newborns (44 extremely preterm newborns (EPNs) at 22–27 weeks' GA, 68 very preterm newborns (VPNs) at 28–31 weeks' GA, and 82 preterm newborns (PNs) at 32–34 weeks' GA). Linear regression analyses were used to correlate GA and UC-s-IL-6 levels. Receiver operating characteristic (ROC) curves analyses were performed for detecting the presence of funisitis, as the histopathological counterpart of FIRS. Results A significant negative correlation between GA and UC-s-IL-6 levels was found in newborns with severe funisitis (r s =  − 0.427, p = 0.004) and those with mild funisitis (r s =  − 0.396, p = 0.025). ROC curve analyses revealed the area under the curve for detecting funisitis were 0.856, 0.837, and 0.622 in EPNs, VPNs, and PNs, respectively. The UC-s-IL-6 cutoff value in EPNs (28.1 pg/mL) exceeded those in VPNs and PNs (3.7 and 3.0 pg/mL, respectively). Conclusion UC-s-IL-6 levels were inversely correlated with GA especially in newborns with funisitis. Such GA dependency of UC-s-IL-6 should be considered for detecting fetal inflammation. Key Points


Sign in / Sign up

Export Citation Format

Share Document